Literature DB >> 19916070

A 12-week regimen of caloric restriction improves levels of adipokines and pro-inflammatory cytokines in Korean women with BMIs greater than 23 kg/m2.

In Seok Lee1, Gina Shin, Ryowon Choue.   

Abstract

INTRODUCTION: Adipose tissue mass (ATM) is an important source of adipokines. Increases in ATM contribute to chronic low-grade inflammation characterized by high levels of pro-inflammatory cytokines. We investigated the effects of body fat reduction on blood levels of adipokines and pro-inflammatory cytokines in Korean women with BMIs >23 kg/m(2).
METHODS: A total of 46 healthy women participated in the study. A registered dietician supervised the subjects as they conformed to a program of caloric restriction during a 12-week experimental period. Anthropometric assessments were carried out, and blood levels of lipids, adipokines, and pro-inflammatory cytokines were analyzed at the beginning and the end of the experiment.
RESULTS: Body weight and body fat mass decreased significantly in our subjects after 12 weeks of caloric restriction (p < 0.001). Blood levels of triacylglycerol were significantly reduced in accordance with body fat reduction. However, the other blood lipid parameters were unchanged. Adipokine, leptin, and visfatin levels decreased significantly, while adiponectin increased significantly (p < 0.05). Levels of pro-inflammatory cytokines TNF-alpha and IFN-gamma were significantly reduced (p < 0.05).
CONCLUSIONS: Our results indicate that body fat reduction via caloric restriction positively affects the blood levels of adipokines and pro-inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19916070     DOI: 10.1007/s00011-009-0113-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  45 in total

1.  Serum interleukin-8 level is increased in diabetic patients.

Authors:  D Zozuliñska; A Majchrzak; M Sobieska; K Wiktorowicz; B Wierusz-Wysocka
Journal:  Diabetologia       Date:  1999-01       Impact factor: 10.122

Review 2.  Adiponectin: more than just another fat cell hormone?

Authors:  Manju Chandran; Susan A Phillips; Theodore Ciaraldi; Robert R Henry
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

Review 3.  Medical consequences of obesity.

Authors:  George A Bray
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

4.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.

Authors:  Atsunori Fukuhara; Morihiro Matsuda; Masako Nishizawa; Katsumori Segawa; Masaki Tanaka; Kae Kishimoto; Yasushi Matsuki; Mirei Murakami; Tomoko Ichisaka; Hiroko Murakami; Eijiro Watanabe; Toshiyuki Takagi; Megumi Akiyoshi; Tsuguteru Ohtsubo; Shinji Kihara; Shizuya Yamashita; Makoto Makishima; Tohru Funahashi; Shinya Yamanaka; Ryuji Hiramatsu; Yuji Matsuzawa; Iichiro Shimomura
Journal:  Science       Date:  2004-12-16       Impact factor: 47.728

5.  Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women.

Authors:  Manny Noakes; Jennifer B Keogh; Paul R Foster; Peter M Clifton
Journal:  Am J Clin Nutr       Date:  2005-06       Impact factor: 7.045

6.  Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity.

Authors:  Alice S Ryan; Dora M Berman; Barbara J Nicklas; Madhur Sinha; Ronald L Gingerich; Grady S Meneilly; Josephine M Egan; Dariush Elahi
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

7.  Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages.

Authors:  Masahiro Kumada; Shinji Kihara; Noriyuki Ouchi; Hideki Kobayashi; Yoshihisa Okamoto; Koji Ohashi; Kazuhisa Maeda; Hiroyuki Nagaretani; Ken Kishida; Norikazu Maeda; Azumi Nagasawa; Tohru Funahashi; Yuji Matsuzawa
Journal:  Circulation       Date:  2004-04-19       Impact factor: 29.690

8.  Effect of a high-protein, energy-restricted diet on body composition, glycemic control, and lipid concentrations in overweight and obese hyperinsulinemic men and women.

Authors:  Emma Farnsworth; Natalie D Luscombe; Manny Noakes; Gary Wittert; Eleni Argyiou; Peter M Clifton
Journal:  Am J Clin Nutr       Date:  2003-07       Impact factor: 7.045

9.  Effect of weight loss and ketosis on postprandial cholecystokinin and free fatty acid concentrations.

Authors:  Supornpim Chearskul; Elizabeth Delbridge; Arthur Shulkes; Joseph Proietto; Adamandia Kriketos
Journal:  Am J Clin Nutr       Date:  2008-05       Impact factor: 7.045

Review 10.  Progress in nutritional immunology.

Authors:  Gabriel Fernandes
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

View more
  9 in total

1.  The effect of Ramadan fasting on quiescent systemic lupus erythematosus (SLE) patients' disease activity, health quality of life and lipid profile: a pilot study.

Authors:  Hamid Goharifar; Seyedeh Tahereh Faezi; Pedram Paragomi; Ali Montazeri; Arash Tehrani Banihashemi; Maryam Akhlaghkhah; Bahar Sadeghi Abdollahi; Zahra Kamazani; Mahmood Akbarian
Journal:  Rheumatol Int       Date:  2015-05-14       Impact factor: 2.631

Review 2.  Caloric restriction and chronic inflammatory diseases.

Authors:  O A González; C Tobia; J L Ebersole; M J Novak
Journal:  Oral Dis       Date:  2011-07-13       Impact factor: 3.511

3.  Contribution of gender and body fat distribution to inflammatory marker concentrations in apparently healthy young adults.

Authors:  Helen Hermana M Hermsdorff; Ana Carolina P Volp; Blanca Puchau; Kiriaque B F Barbosa; M Angeles Zulet; Josefina Bressan; J Alfredo Martínez
Journal:  Inflamm Res       Date:  2012-01-19       Impact factor: 4.575

4.  Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors.

Authors:  Stephanie M George; Marian L Neuhouser; Susan T Mayne; Melinda L Irwin; Demetrius Albanes; Mitchell H Gail; Catherine M Alfano; Leslie Bernstein; Anne McTiernan; Jill Reedy; Ashley W Smith; Cornelia M Ulrich; Rachel Ballard-Barbash
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-17       Impact factor: 4.254

5.  Kinetic assessment and therapeutic modulation of metabolic and inflammatory profiles in mice on a high-fat and cholesterol diet.

Authors:  Laura W Engstrom; Loretta Bober; Shu-Cheng Chen; Jay S Fine; Ying Li; Michaela C Stanton; David Kinsley; Long Cui; James V Jackson; Alberto Rojas-Triana; Daniel Lundell; Maureen Laverty; Eric L Gustafson; Chung-Her Jenh; Timothy J Kowalski; Denise J Manfra
Journal:  PPAR Res       Date:  2010-04-22       Impact factor: 4.964

Review 6.  Obesity, immunomodulation and chronic kidney disease.

Authors:  Emma Börgeson; Kumar Sharma
Journal:  Curr Opin Pharmacol       Date:  2013-06-07       Impact factor: 5.547

Review 7.  Calorie Restriction as a New Treatment of Inflammatory Diseases.

Authors:  Tunay Kökten; Franck Hansmannel; Ndeye Coumba Ndiaye; Anne-Charlotte Heba; Didier Quilliot; Natacha Dreumont; Djésia Arnone; Laurent Peyrin-Biroulet
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

8.  Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease.

Authors:  Hwi Young Kim; Su Jung Baik; Hye Ah Lee; Byoung Kwon Lee; Hye Sun Lee; Tae Hun Kim; Kwon Yoo
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

Review 9.  Using Intermittent Fasting as a Non-pharmacological Strategy to Alleviate Obesity-Induced Hypothalamic Molecular Pathway Disruption.

Authors:  Luciana da Costa Oliveira; Gustavo Paroschi Morais; Eduardo R Ropelle; Leandro P de Moura; Dennys E Cintra; José R Pauli; Ellen C de Freitas; Rodrigo Rorato; Adelino Sanchez R da Silva
Journal:  Front Nutr       Date:  2022-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.